Sequent Scientific Ltd.

₹184.18

Sequent Scientific Ltd.

Add Alert
Add Watchlist

₹184.18

₹184.18

-5.35 (-2.82%) - 29 Sep 2025 04:25 PM

About Company

SeQuent is looking towards the future with courage and confidence, because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation). The company branded its Animal Health business as Alivira Animal Health with a singular focus to create value in the global animal health space. It caters to unaddressed global market requirements and focus on products for livestock, poultry and companion animals.

Market Cap. ₹ 4,635 Cr.
52 Week - High/Low ₹ 241/92
P/E Ratio 317.55
P/B Ratio 4.06
Enterprise Value ₹ 4,657 Cr.
ROE % 1.54
RSI Value 46.75
EMA 50 183.92
EMA 200 173.37
Market Cap. ₹ 4,635 Cr.
52 Week - High/Low ₹ 241/92
P/E Ratio 156.08
P/B Ratio 6.58
Enterprise Value ₹ 4,829 Cr.
ROE % 5.44
RSI Value 46.75
EMA 50 183.92
EMA 200 173.37

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.